Manual

Manual, a London-based B2C platform, offers diagnostic tools and testing to help patients make informed health decisions. As healthcare digitalizes, Manual meets growing consumer demand for accessible, immediate health insights, setting itself apart from traditional doctor visits and lab tests that can be time-consuming and intimidating. Its convenience and direct-to-consumer model position it well against competitors offering at-home test kits. However, the company must ensure the reliability and accuracy of its tools to mitigate potential health risks from delayed or uninformed decisions. Supported by investors like Felix Capital, Cherry Ventures, and FJ Labs, Manual is poised for rapid growth, leveraging health tech innovation and consumer convenience.